It was the pharma that everyone wanted to work for - be careful what you wish for! - Director bei Merck: Mitarbeiterbewertung

3,0
11. Dez. 2011
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Excellent workplace flexibility - I could work from home whenever I needed to. Company store - cheap Merck products Good salaries and benefits Really good people - peers. Everyone works really hard and understands the company mission to save lives and make people feel better.

Kontras

Upper management thinks they know what everyone is doing but in truth, do not. People are afraid to say what they think - no "courage and candor" although the company lists this as a core competency. People have gotten their "hands slapped" for speaking up and giving opinions (especially after the merger with Schering-Plough). Company downsizing in order to keep up with the economy, but they don't seem to be changing how they operate in a changing Pharma environment. When the merger happened, Merck said they wanted to have a culture more like Schering but after 2 years, it has reverted to the "old Merck" - see comment on courage and candor.

Mehr Bewertungen zu Merck entdecken

5,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Excellent company to work with.

Kontras

No cons encountered so far

4,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Kontras

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle